Publication Information

{'id': 'https://openalex.org/W4248316145', 'doi': 'https://doi.org/10.1002/9781119220787.ch50', 'title': 'DAKLINZA (Daclatasvir)', 'display_name': 'DAKLINZA (Daclatasvir)', 'publication_year': 2017, 'publication_date': '2017-08-30', 'ids': {'openalex': 'https://openalex.org/W4248316145', 'doi': 'https://doi.org/10.1002/9781119220787.ch50'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/9781119220787.ch50', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'other', 'type_crossref': 'other', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5001033479', 'display_name': 'David Schlossberg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I84392919', 'display_name': 'Temple University', 'ror': 'https://ror.org/00kx1jb78', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I84392919']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Schlossberg MD, FACP, FIDSA, FCPP', 'raw_affiliation_strings': ['The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA'], 'affiliations': [{'raw_affiliation_string': 'The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA', 'institution_ids': ['https://openalex.org/I84392919']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5111525165', 'display_name': 'Rafik Samuel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I84392919', 'display_name': 'Temple University', 'ror': 'https://ror.org/00kx1jb78', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I84392919']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rafik Samuel MD, FACP, FIDSA, FCPP', 'raw_affiliation_strings': ['The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA'], 'affiliations': [{'raw_affiliation_string': 'The Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA', 'institution_ids': ['https://openalex.org/I84392919']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': None, 'issue': None, 'first_page': '112', 'last_page': '113'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11663', 'display_name': 'Viral Infectious Diseases and Gene Expression in Insects', 'score': 0.9153, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11663', 'display_name': 'Viral Infectious Diseases and Gene Expression in Insects', 'score': 0.9153, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/daclatasvir', 'display_name': 'Daclatasvir', 'score': 0.9983902}, {'id': 'https://openalex.org/keywords/sofosbuvir', 'display_name': 'Sofosbuvir', 'score': 0.775383}, {'id': 'https://openalex.org/keywords/ns5a', 'display_name': 'NS5A', 'score': 0.6916377}], 'concepts': [{'id': 'https://openalex.org/C2776979040', 'wikidata': 'https://www.wikidata.org/wiki/Q5207712', 'display_name': 'Daclatasvir', 'level': 5, 'score': 0.9983902}, {'id': 'https://openalex.org/C2778390639', 'wikidata': 'https://www.wikidata.org/wiki/Q2502747', 'display_name': 'Sofosbuvir', 'level': 5, 'score': 0.775383}, {'id': 'https://openalex.org/C2777103181', 'wikidata': 'https://www.wikidata.org/wiki/Q83141840', 'display_name': 'NS5A', 'level': 5, 'score': 0.6916377}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.61839205}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5970248}, {'id': 'https://openalex.org/C2780040827', 'wikidata': 'https://www.wikidata.org/wiki/Q421862', 'display_name': 'Ribavirin', 'level': 4, 'score': 0.49420145}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.35528478}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32497472}, {'id': 'https://openalex.org/C2776408679', 'wikidata': 'https://www.wikidata.org/wiki/Q708693', 'display_name': 'Hepatitis C virus', 'level': 3, 'score': 0.28592366}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.26113158}, {'id': 'https://openalex.org/C2781463415', 'wikidata': 'https://www.wikidata.org/wiki/Q2082778', 'display_name': 'Hepacivirus', 'level': 4, 'score': 0.09684202}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/9781119220787.ch50', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.71, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3211868267', 'https://openalex.org/W3025283773', 'https://openalex.org/W3025253505', 'https://openalex.org/W2982696294', 'https://openalex.org/W2910233825', 'https://openalex.org/W2516395986', 'https://openalex.org/W2172454869', 'https://openalex.org/W2024150911', 'https://openalex.org/W1990772217', 'https://openalex.org/W1980771473'], 'abstract_inverted_index': {'This': [0], 'chapter': [1], 'provides': [2], 'the': [3, 13, 19, 37, 40, 48, 58, 81, 130], 'basic': [4], 'characteristics,': [5], 'side': [6], 'effects/toxicity,': [7], 'drug': [8], 'interactions,': [9], 'and': [10, 26, 32, 66, 104, 148], 'dosing': [11], 'of': [12, 21, 39, 50, 83], 'daklinza': [14], '(daclatasvir).': [15], 'Daclatasvir': [16, 69, 113, 141], 'binds': [17], 'to': [18, 45, 55, 119, 133, 138], 'N-terminus': [20], 'nonstructural': [22], 'protein': [23, 42], '5A': [24], '(NS5A)': [25], 'inhibits': [27], 'both': [28], 'viral': [29], 'RNA': [30], 'replication': [31, 44], 'virion': [33], 'assembly.': [34], 'Alterations': [35], 'in': [36, 47, 100, 125, 143], 'structure': [38], 'NS5A': [41], 'allow': [43], 'continue': [46], 'presence': [49], 'daclatasvir.': [51], 'The': [52], 'mutations': [53], 'leading': [54], 'resistance': [56], 'include': [57], 'M28T,': [59], 'Q30E,': [60], 'Q30H,': [61], 'Q30R,': [62], 'L31V,': [63], 'Y93C,': [64], 'Y93H,': [65], 'Y93N': [67], 'substitutions.': [68], 'is': [70, 123], 'indicated': [71], 'for': [72, 80, 110], 'use': [73], 'with': [74, 76, 85, 102, 127], 'sofosbuvir,': [75], 'or': [77, 93], 'without': [78, 117], 'ribavirin,': [79], 'treatment': [82], 'patients': [84], 'chronic': [86], 'hepatitis': [87], 'C': [88], 'virus': [89], '(HCV)': [90], 'genotype': [91, 94], '1': [92], '3': [95], 'infection.': [96], 'Patients': [97], 'taking': [98], 'daclatasvir': [99, 122], 'combination': [101, 126, 139], 'sofosbuvir': [103], 'amiodarone': [105], 'are': [106, 136], 'at': [107], 'high': [108], 'risk': [109], 'symptomatic': [111], 'bradycardia.': [112], 'may': [114], 'be': [115], 'taken': [116], 'regard': [118], 'food.': [120], 'When': [121], 'used': [124], 'other': [128], 'agents,': [129], 'contraindications': [131], 'applicable': [132, 137], 'those': [134], 'agents': [135], 'therapies.': [140], 'comes': [142], '30': [144], 'mg,': [145, 147], '60': [146], '90': [149], 'mg': [150], 'tablets.': [151]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4248316145', 'counts_by_year': [], 'updated_date': '2024-12-10T23:47:40.272859', 'created_date': '2022-05-12'}